Showing results (1961-1970 of 2,215) with videos related to

Sort By:
Pageof 222
Microbial Ecology|August 25, 2018
Co-occurrence of Anaerobes in Human Chronic WoundsYongwook Choi, Anirban Banerjee, Sean McNish, et al.
Pain Physician|December 2, 2024
Nucleus Pulposus Allograft Supplementation in Patients with Lumbar Discogenic Pain: Initial 6-month Outcomes from a Prospective Clinical Pilot StudyDouglas P Beall, Timothy T Davis, Kasra Amirdelfan, et al.
Clinical Pharmacology and Therapeutics|January 18, 2025
A 2024 Update on US FDA Implementation of Partial Area Under the Curve Into Bioavailability and Bioequivalence AssessmentsRobert Hopefl, Yuqing Gong, Elizabeth Bielski, et al.
Journal of Pain Research|September 13, 2021
Pain Relief Salvage with a Novel Minimally Invasive Posterior Sacroiliac Joint Fusion Device in Patients with Previously Implanted Pain Devices and TherapiesTimothy R Deer, Adam Rupp, Ryan Budwany, et al.
Clinical Pharmacology and Therapeutics|July 31, 2026
Pediatric Extrapolation in Neuropsychiatric Drug Development: Leveraging Pharmacokinetic and Pharmacodynamic Strategies to Facilitate FDA ApprovalsAnantha Ram Nookala, William A Murphy, Nimishraj Panse, et al.
Chembiochem : a European Journal of Chemical Biology|February 20, 2016
New p32/gC1qR Ligands for Targeted Tumor Drug DeliveryLauri Paasonen, Shweta Sharma, Gary B Braun, et al.
Tumour Biology : the Journal of the International Society for Oncodevelopmental Biology and Medicine|May 5, 2017
Hyaluronan-binding peptide for targeting peritoneal carcinomatosisHideki Ikemoto, Prakash Lingasamy, Anne-Mari Anton Willmore, et al.
International Journal of Oncology|June 16, 2011
Antitumor activity of NRC-AN-019 in a pre-clinical breast cancer modelChristopher S Gondi, Bharathi Gorantla, A K S Bhujanga Rao, et al.
Chemico-Biological Interactions|March 1, 2011
Aldose reductase inhibition suppresses oxidative stress-induced inflammatory disordersSatish K Srivastava, Umesh C S Yadav, Aramati B M Reddy, et al.
Scientific Reports|March 25, 2018
Radiomic MRI signature reveals three distinct subtypes of glioblastoma with different clinical and molecular characteristics, offering prognostic value beyond IDH1Saima Rathore, Hamed Akbari, Martin Rozycki, et al.
Pageof 222